about
PSA and beyond: alternative prostate cancer biomarkersRepair of oxidative DNA damage and cancer: recent progress in DNA base excision repairBiomarkers in prostate cancer: what's new?Analysis to Estimate Genetic Variations in the Idarubicin-Resistant Derivative MOLT-3.A novel mouse model for ataxia-telangiectasia with a N-terminal mutation displays a behavioral defect and a low incidence of lymphoma but no increased oxidative burden.Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients.Cancer as a mitochondrial metabolic disease.Mitochondrial A12308G alteration in tRNA(Leu(CUN)) in colorectal cancer samples.Mitochondrial DNA Mutations in Grade II and III Glioma Cell Lines Are Associated with Significant Mitochondrial Dysfunction and Higher Oxidative StressA multi-parametric workflow for the prioritization of mitochondrial DNA variants of clinical interestLow copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in early-stage laryngeal cancer patients.Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy.High mitochondrial DNA copy number was associated with an increased gastric cancer risk in a Chinese population.Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1.Press-pulse: a novel therapeutic strategy for the metabolic management of cancer.Methylation of mitochondrial DNA displacement loop region regulates mitochondrial copy number in colorectal cancer.Identifying selectively important amino acid positions associated with alternative habitat environments in fish mitochondrial genomes.Myricetin Selectively Induces Apoptosis on Cancerous Hepatocytes by Directly Targeting Their Mitochondria.Detection of somatic mutations in the mitochondrial DNA control region D-loop in brain tumors: The first report in Malaysian patients.The influence of ketogenic therapy on the 5 R's of radiobiology.Mitochondrial 10398A>G NADH-Dehydrogenase Subunit 3 of Complex I Is Frequently Altered in Intra-Axial Brain Tumors in Malaysia.Compound Fuling Granule Suppresses Ovarian Cancer Development and Progression by disrupting mitochondrial function, galactose and fatty acid metabolism
P2860
Q26770646-F56B67CF-7867-4AD8-BF03-123CDE296680Q26822957-132E14B3-A59C-4930-BEDF-421281AB0098Q27026210-80F50FF5-5D42-4D6B-BB60-BE9BF25A8E08Q30396832-B96ADB80-F613-4ABD-AB67-6BAE0FCE81F8Q30806557-8C18AFAD-3FA4-44A5-A5BB-74254B4A0CCFQ33589639-045FD267-9D58-418D-A494-82E756184559Q35824628-BC128566-8F44-4E60-9F8C-5967F26053AEQ35864177-8D23B753-15C7-4B51-9046-6DC58FDD651CQ36366516-FA09448B-D464-465E-AAB4-9FD65E11B3B1Q36422135-B44FBAC8-163E-4ACC-BA21-DD6CC1FAFCDAQ37564494-94A2816C-98D0-4C44-A0F1-2C0F3775D512Q38741503-4F6A77F3-536B-48D9-AC1D-F338CBB8C148Q40131095-B7BA5B29-EB8F-4505-984A-4F3F3A261088Q41345087-F1BB0B26-55E0-4B6F-8480-1AECF601A174Q41989445-7E2CBC84-8A14-4631-8AE9-14ECCB7D91A2Q42679036-39C552D8-3A92-48F7-A3D4-C2E6895C6280Q46380687-6F07BFAD-495B-4137-BEB1-2279106F9AB7Q46589517-78BA4A78-4A1D-47E3-A0EF-9359A35BD1E8Q47133228-031F5EEB-1643-48A2-BA3F-4FE368CE6868Q47987478-5E495EBF-3D4E-49AA-8801-2D63D6C7A1F3Q55374400-A875BABA-C9C3-4232-ADE6-5D416C4A3D21Q57116347-DDAA323D-43B7-4DA5-B543-7BBA46BE2006
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Mitochondria and cancer: past, present, and future.
@en
Mitochondria and cancer: past, present, and future.
@nl
type
label
Mitochondria and cancer: past, present, and future.
@en
Mitochondria and cancer: past, present, and future.
@nl
prefLabel
Mitochondria and cancer: past, present, and future.
@en
Mitochondria and cancer: past, present, and future.
@nl
P2093
P2860
P921
P356
P1476
Mitochondria and cancer: past, present, and future.
@en
P2093
A Harbottle
J P Jakupciak
M L Verschoor
P2860
P304
P356
10.1155/2013/612369
P407
P5008
P577
2013-01-28T00:00:00Z